Mitochondrial dysfunction is a key determinant of the rare disease lymphangioleiomyomatosis and provides a novel therapeutic target

E. M. M. Abdelwahab, S. Pal, K. Kvell, V. Sarosi, P. Bai, R. Rue, V. Krymskaya, D. McPhail, A. Porter, J. E. Pongracz (Corresponding Author)

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)
9 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Mitochondrial dysfunction is a key determinant of the rare disease lymphangioleiomyomatosis and provides a novel therapeutic target'. Together they form a unique fingerprint.

Medicine & Life Sciences